Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Apraclonidine

66711-21-5C9H10Cl2N4245.113 g/mol

An imidazoline that is 2-amino 4,5-dihydro-1H-imidazoline in which one of the exocyclic amino hydrogens has been replaced by a 4-amino-2,6-dichlorophenyl group. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number66711-21-5ChEBI ↗
Molecular formulaC9H10Cl2N4ChEBI ↗
Molar mass245.113 g/molChEBI ↗
Monoisotopic mass244.02825 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:2788ChEBI ↗

Cross-source molecular data

PubChem
Molar mass245.11 g/molPubChem ↗
Exact mass244.0282517 DaPubChem ↗
Computed XLogP1.3PubChem ↗
Topological polar surface area (Ų)62.4PubChem ↗
H-bond donors3PubChem ↗
H-bond acceptors2PubChem ↗
Rotatable bonds2PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
apraclonidine
2,6-dichloro-N(1)-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine
IEJXVRYNEISIKR-UHFFFAOYSA-N
Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1
InChI=1S/C9H10Cl2N4/c10-6-3-5(12)4-7(11)8(6)15-9-13-1-2-14-9/h3-4H,1-2,12H2,(H2,13,14,15)

Names & synonyms

2,6-dichloro-N(1)-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamineapraclonidinaapraclonidinum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

diagnostic agentbeta-adrenergic agonistalpha-adrenergic agonistantiglaucoma drugophthalmology drug

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00407975 mol

Uses 245.113 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 9 atoms
44.10%
Cl
Chlorine · 2 atoms
28.93%
N
Nitrogen · 4 atoms
22.86%
H
Hydrogen · 10 atoms
4.11%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Topical apraclonidine testing of pupillary sympathetic denervation in diabetic patients. ↗Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society · 2006 Dec · PMID 17204928
Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants. ↗Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus · 2007 Jun · PMID 17572343
US4517199 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:2788

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 2216 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.